COL6A3 and chronic kidney disease: The biomarker of COL6 formation, PRO-C6, can also quantify the profibrotic and proinflammatory COL6A3-derived molecule endotrophin, which has been shown to be a common biomarker of the risk of chronic kidney disease (CKD) and CVD.